Integra LifeSciences Holdings Corporation (IART) Social Stream
Integra Lifesciences Holdings Corp (IART) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Integra Lifesciences Holdings Corp.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
IART's average price target has moved up $10.83 over the prior 13 months.
IART reports an average of 9.76% for its upside potential over the past 47 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
IART Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 23 months, IART's average broker recommendation rating worsened by 0.05.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Integra Lifesciences Holdings Corp fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 120.25% of that group.
- In the context of stocks in the mid market cap category, Integra Lifesciences Holdings Corp's average analyst price target is higher than 602.56% of them.
- Integra Lifesciences Holdings Corp's variance in analysts' estimates is lower than -141.49% of Healthcare stocks.
- In terms of how Integra Lifesciences Holdings Corp fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 511.66% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to Integra Lifesciences Holdings Corp are HAE, GMED, and GKOS.
Make investment decisions regarding IART using the data that counts. Try POWR Ratings for free.